-
Vaccines, Blood & Biologics
-
Resources for You
-
-
Blood Safety & Availability
-
Key Resources
- Bovine Spongiform Encephalopathy (BSE)
- Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rho(D) immune globulin intravenous administration for immune thrombocytopenic purpura (PDF - 68KB)
- Investigation of whether the acute hemolysis associated with Rho(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model (PDF - 150KB)
- Keeping Blood Transfusions Safe: FDA's Multi-layered Protections for Donated Blood
- Mercury in Plasma-Derived Products
- Potential Risk of Variant Creutzfeldt-Jakob Disease (vCJD) From Plasma-Derived Products
- Safety of Albumin Administration in Critically Ill Patients
- Public Workshop: Safety of Hemoglobin-Based Oxygen Carriers (HBOCs)
- Severe Acute Respiratory Syndrome (SARS) Information
- FDA Workshop on Testing for Malarial Infections in Blood Donors
- Transfusion Related Acute Lung Injury (TRALI)
-
-
Recalls & Alerts
-
Contact Us
- (800) 835-4709
- (301) 827-1800
- ocod@fda.hhs.gov
Consumer Affairs Branch (CBER)
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448
-
-
-